Skip to main content

HER2 status differed between primary tumor and CTCs in 18.8% of women with MBC

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
HER2 status differed between primary tumor and CTCs in 18.8% of women with MBC

User login

Username

Password

Reset your password

Type	Lead	score